Literature DB >> 28839610

What you need to know when you prescribe a proton pump inhibitor.

A Norman1, C J Hawkey1.   

Abstract

Ever since they were launched, proton pump inhibitors (PPIs) have been regarded as profligate prescription interventions and have become a favourite target for pharmacy advisers. Now that they are cheap, with generic omeprazole 20 mg daily costing £1.88 per month (£24.51 per annum) in the UK, it is time to ask whether this status should be reviewed, whether there are areas where the message should be reversed and whether there are any circumstances in which the extra cost of branded PPIs or combined preparations is justified. Equally, with the recognition of an extended toxicity profile, is prescribing profligacy not an economic but a safety issue?

Entities:  

Year:  2011        PMID: 28839610      PMCID: PMC5517237          DOI: 10.1136/flgastro-2011-100006

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  43 in total

1.  Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study.

Authors:  D Keszthelyi; S V Jansen; G A Schouten; S de Kort; B Scholtes; L G J B Engels; A A M Masclee
Journal:  Aliment Pharmacol Ther       Date:  2010-09-13       Impact factor: 8.171

2.  Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy.

Authors:  H Koop; M G Bachem
Journal:  J Clin Gastroenterol       Date:  1992-06       Impact factor: 3.062

3.  Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Authors:  Francis K L Chan; Jessica Y L Ching; Lawrence C T Hung; Vincent W S Wong; Vincent K S Leung; Nelson N S Kung; Aric J Hui; Justin C Y Wu; Wai K Leung; Vivian W Y Lee; Kenneth K C Lee; Yuk T Lee; James Y W Lau; Ka F To; Henry L Y Chan; S C Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

4.  Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.

Authors:  Wayne A Ray; Katherine T Murray; Marie R Griffin; Cecilia P Chung; Walter E Smalley; Kathi Hall; James R Daugherty; Lisa A Kaltenbach; C Michael Stein
Journal:  Ann Intern Med       Date:  2010-03-16       Impact factor: 25.391

5.  A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

Authors:  N D Yeomans; Z Tulassay; L Juhász; I Rácz; J M Howard; C J van Rensburg; A J Swannell; C J Hawkey
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

6.  Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Authors:  J Y Lau; J J Sung; K K Lee; M Y Yung; S K Wong; J C Wu; F K Chan; E K Ng; J H You; C W Lee; A C Chan; S C Chung
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

7.  Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.

Authors:  Alan N Barkun; Viviane Adam; Joseph J Y Sung; Ernst J Kuipers; Joachim Mössner; Dennis Jensen; Robert Stuart; James Y Lau; Emma Nauclér; Jan Kilhamn; Helena Granstedt; Bengt Liljas; Tore Lind
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs.

Authors:  J Weil; M J Langman; P Wainwright; D H Lawson; M Rawlins; R F Logan; T P Brown; M P Vessey; M Murphy; D G Colin-Jones
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

9.  International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

10.  Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome.

Authors:  Jeremy A Rassen; Niteesh K Choudhry; Jerry Avorn; Sebastian Schneeweiss
Journal:  Circulation       Date:  2009-11-23       Impact factor: 29.690

View more
  2 in total

1.  Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations.

Authors:  Hyeon-Cheol Jeong; Min-Gul Kim; Zhuodu Wei; Kyeong-Ryoon Lee; Jaehyeok Lee; Im-Sook Song; Kwang-Hee Shin
Journal:  Pharmaceutics       Date:  2022-06-18       Impact factor: 6.525

2.  Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software.

Authors:  Sanjida Akter; Md Rajib Hassan; Mohammad Shahriar; Nahia Akter; Md Golam Abbas; Mohiuddin Ahmed Bhuiyan
Journal:  Alzheimers Res Ther       Date:  2015-12-27       Impact factor: 6.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.